Author:
Morishita Nobumichi,Tomono Yoshiro,Hasegawap Jiro,Branagan Paul,Houston A. C.,Weber Werner,Heuer Horst-Jürgen,Pabst Günther
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine,Pharmacology (medical)
Reference10 articles.
1. Baba T, Tomiyama T, Murabayashi S, Takebe K. Renal effects of bunazosin, a new α1-adrenoceptor blocker, in patients with mild-to-moderate essential hypertension. Journal of Cardiovascular Pharmacology 15: 826–830, 1990
2. Donnelly R, Meredith PA, Elliott HL. Pharmacokinetic-pharmacodynamic relationships of α-adrenoceptor antagonists. Clinical Pharmacokinetics 17: 264–274, 1989
3. Hashimoto S, Oshita M, Morikawa K, Kato H, Ito Y, et al. In vitro pharmacological profile of the novel α1 -adrenoceptor antagonist HSR-175. Japanese Journal of Pharmacology 59: 379–385, 1992
4. Igarashi T, Nakajima Y, Ohtake S. Comparison of alpha blocking agents on blood pressure and heart rate in unanesthetised spontaneously hypertensive (SHR) and normotensive rats. Clinical and Experimental Pharmacology and Physiology 3 (Suppl.): 89–92, 1976
5. Kawasaki T, Uezono K, Abe I. Antihypertensive effects of E-643, a new alpha-adrenergic agent. European Journal of Clinical Pharmacology 20: 399–405, 1981